Home/Filings/4/A/0001209191-15-087441
4/A//SEC Filing

Bone Biologics Corp 4/A

Accession 0001209191-15-087441

$BBLGCIK 0001419554operating

Filed

Dec 29, 7:00 PM ET

Accepted

Dec 30, 8:40 PM ET

Size

5.7 KB

Accession

0001209191-15-087441

Insider Transaction Report

Form 4/AAmended
Period: 2014-11-04
Walsh Deina H
Chief Financial Officer
Transactions
  • Other

    Employee Option (Right to Buy)

    2014-11-04174,9180 total
    Exercise: $1.00Common Stock (174,918 underlying)
Footnotes (1)
  • [F1]This Form 4 Amendment is being filed to report that the option grant reported on Form 4 filed with the Securities and Exchange Commission on October 27, 2015 was granted under an equity incentive plan that never became effective and, as a result, the option was never validly issued.

Issuer

Bone Biologics Corp

CIK 0001419554

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001419554

Filing Metadata

Form type
4/A
Filed
Dec 29, 7:00 PM ET
Accepted
Dec 30, 8:40 PM ET
Size
5.7 KB